Bo Saxberg, M.D., Ph.D.
Dr. Saxberg is originally from Seattle, Washington in the United States. He attended the University of Washington there, receiving Summa Cum Laude an Honors B.S. degree in Mathematics and an Honors B.S. degree in Chemistry. He then attended Cambridge University in England, earning an Honours B.A./M.A. Cantab. in Physics. Returning to the United States, he received an M.D. degree from Harvard and his Ph.D. in Physics from the Massachusetts Institute of Technology.
Dr. Saxberg was a National Institutes of Health Fellow at MIT from 1989 to 1991, prior to joining Eli Lilly in Indianapolis as a Senior Research Scientist, continuing his prior research interests in QSAR/genomics/proteomics/physiomics. In 1993, Dr. Saxberg was named Director of Information Sciences at Eli Lilly. This group subsequently led a number of industry pioneering efforts at Lilly, including the first Internet home page for a pharmaceutical company, as well as developing interactive health economic models evolving to disease management, point of care prescribing, and the development of information resources to support modern product portfolio resource allocation decisions.
Dr. Saxberg joined Johnson & Johnson in 1995 as Vice President, Corporate Staff, Advanced Communications, leading Johnson & Johnson’s efforts in Medical Informatics, focusing on new business opportunities related to information technology in healthcare delivery and product development. As part of these efforts, working with both internal and external venture capital resources as well as member companies, the Advanced Communications Group helped to develop for J&J pioneering creation or investment positions ranging from defined contribution employee benefit models of health insurance, real-time auto-adjudication networks at the point of care supporting cost-quality decisions between doctor and patient, and a variety of technologies in health informatics including telemedicine, clinical studies and outcomes measurement, and electronic medical records. Working with the J&J international pharmaceutical group, innovative programs were created in the development of iterative customer relationships based on clinical information, creating demonstration of product value. Dr. Saxberg and members of the Advanced Communications Group also led the development and implementation of Johnson & Johnson’s global policies and procedures for the Internet, including privacy policies, to construct a policy platform to enable future business needs.
As of 2002, Dr. Saxberg left Johnson & Johnson to become founder and Pres., DDO Strategic Services, LLC, (“Design Development Optimization”). He is continuing his prior work in consulting, venture formation and business development with companies seeking to take leading advantage of change driven by new technologies and information access in health care, with application to product research & development, product and service marketing, financial services innovation, and clinical service innovation. Dr. Saxberg is a management/advisory board member for a number of entrepreneurial companies, associations and venture firms, including PhDx, Exagen, Medidata, Boston Millennia Partners, Village Ventures, the Institute for the Future, and the Columbia University Center for Advanced Technology.